» Articles » PMID: 30366255

Investigating Alkyl Nitrates As Nitric Oxide Releasing Precursors of Multitarget Acetylcholinesterase-monoamine Oxidase B Inhibitors

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2018 Oct 27
PMID 30366255
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Herein we envisaged the possibility of exploiting alkyl nitrates as precursors of alcohol-bearing dual inhibitors targeting acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), key enzymes in neurodegenerative syndromes such as Alzheimer's disease (AD), through biotransformation unmasking an alcoholic function upon nitric oxide (NO) release. The cooperation to neuroprotection of low fluxes of NO and target enzymes' inhibition by the alcohol metabolites might return a multitargeting effect. The in vitro screening towards ChEs and MAOs of a collection of 21 primary alcohols disclosed a subset of dual inhibitors, among which three diverse chemotypes were selected to study the corresponding nitrates. Nitrate 14 proved to be a brain permeant, potent AChE-MAO B inhibitor by itself. Moreover, it protected human SH-SY5Y lines against rotenone and hydrogen peroxide with a poor inherent cytotoxicity and showed a slow conversion profile to its alcohol metabolite 9d that still behaved as bimodal and neuroprotective molecule.

Citing Articles

Coumarin Derivative Hybrids: Novel Dual Inhibitors Targeting Acetylcholinesterase and Monoamine Oxidases for Alzheimer's Therapy.

Zolek T, Purgatorio R, Klopotowski L, Catto M, Ostrowska K Int J Mol Sci. 2024; 25(23).

PMID: 39684512 PMC: 11641184. DOI: 10.3390/ijms252312803.


Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells.

Arduino I, Di Fonte R, Sommonte F, Lopedota A, Porcelli L, Li J Int J Nanomedicine. 2024; 19:13217-13233.

PMID: 39679250 PMC: 11638480. DOI: 10.2147/IJN.S489872.


Chitosan and Anionic Solubility Enhancer Sulfobutylether-β-Cyclodextrin-Based Nanoparticles as Dexamethasone Ophthalmic Delivery System for Anti-Inflammatory Therapy.

Racaniello G, Balenzano G, Arduino I, Iacobazzi R, Lopalco A, Lopedota A Pharmaceutics. 2024; 16(2).

PMID: 38399331 PMC: 10893235. DOI: 10.3390/pharmaceutics16020277.


Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease.

Zou D, Liu R, Lv Y, Guo J, Zhang C, Xie Y J Enzyme Inhib Med Chem. 2023; 38(1):2270781.

PMID: 37955252 PMC: 10653629. DOI: 10.1080/14756366.2023.2270781.


Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease.

Hafez D, Dubiel M, La Spada G, Catto M, Reiner-Link D, Syu Y J Enzyme Inhib Med Chem. 2023; 38(1):2175821.

PMID: 36789662 PMC: 9937012. DOI: 10.1080/14756366.2023.2175821.